Home/Medicines/Desoxycorticosterone Pivalate (DOCP)
All medicines

Desoxycorticosterone Pivalate (DOCP)

Prescription
Mineralocorticoid
Last reviewed 21 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
2 available
Interactions
1 documented
Formulations
1

Mechanism of action

Synthetic mineralocorticoid that promotes sodium and water reabsorption and potassium excretion. Replaces aldosterone in hypoadrenocorticism (Addison's disease). No glucocorticoid activity — supplemental prednisone needed.

At a glance

Class
Mineralocorticoid
Schedule
Prescription
Storage
Store at room temperature; shake well; do not freeze

Dosing

🐕

Dog

Gold standard for mineralocorticoid replacement in Addison's disease
Dose
2.2 mg/kg
Route
IM, SQ
Frequency
q25–28 days
🐈

Cat

Feline hypoadrenocorticism is rare but documented
Dose
2.2 mg/kg
Route
IM, SQ
Frequency
q25 days

Formulations

💊

Other — 1

Strength
—

Storage

Store at room temperature; shake well; do not freeze

Safety

Monitoring parameters

Serum electrolytes (Na, K) and Na:K ratio at day 14 and 25Renal functionBlood pressureClinical well-being

Interactions

Major — 1

Spironolactone
major
DOCP replaces aldosterone in Addison's disease. Spironolactone blocks aldosterone receptors, directly antagonizing DOCP's mineralocorticoid effect — causes hyperkalemia and sodium loss.
Management: NEVER combine. Spironolactone would negate DOCP treatment for Addison's disease.

Brands

Other markets

Percorten-V
Zycortal

FAQs

Frequently asked questions

›What is Desoxycorticosterone Pivalate (DOCP)?
Desoxycorticosterone Pivalate (DOCP) is a mineralocorticoid used in pets. Synthetic mineralocorticoid that promotes sodium and water reabsorption and potassium excretion. Replaces aldosterone in hypoadrenocorticism (Addison's disease). No glucocorticoid activity — supplemental prednisone needed.
›What is Desoxycorticosterone Pivalate (DOCP) used for in pets?
Desoxycorticosterone Pivalate (DOCP) is used in veterinary medicine for: Gold standard for mineralocorticoid replacement in Addison's disease; Feline hypoadrenocorticism is rare but documented.
›What is the Desoxycorticosterone Pivalate (DOCP) dose for dogs?
For dogs, Desoxycorticosterone Pivalate (DOCP) is typically dosed as follows — Gold standard for mineralocorticoid replacement in Addison's disease: 2.2 mg/kg IM/SQ q25–28 days. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Desoxycorticosterone Pivalate (DOCP) dose for cats?
For cats, Desoxycorticosterone Pivalate (DOCP) is typically dosed as follows — Feline hypoadrenocorticism is rare but documented: 2.2 mg/kg IM/SQ q25 days. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Desoxycorticosterone Pivalate (DOCP) need a prescription?
Yes. Desoxycorticosterone Pivalate (DOCP) is a prescription medication and should only be administered under veterinary supervision.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →

Related medicines

Other medicines in the same class (Mineralocorticoid).

DOCP (Desoxycorticosterone Pivalate)
Rx
Long-acting synthetic mineralocorticoid that replaces aldosterone function; promotes sodium retention and potassium excretion in the renal distal tubules, correcting the electrolyte imbalances of hypoadrenocorticism (Addison's disease)
dog